Chemed (CHE) Capital Expenditures (2009 - 2026)

Chemed (CHE) has reported Capital Expenditures for 18 consecutive years, with $17.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures rose 28.89% year-over-year to $17.1 million; the TTM figure through Mar 2026 stood at $66.6 million (up 31.56% YoY), while the FY2025 annual figure was $62.8 million, up 26.78% from the prior year.
• Capital Expenditures came in at $17.1 million for Q1 2026 at Chemed, up from $16.3 million in the prior quarter.
• The five-year high for Capital Expenditures was $18.3 million in Q4 2022, with the low at $11.1 million in Q2 2024.
• Average Capital Expenditures over 5 years is $14.3 million, with a median of $13.5 million recorded in 2022.
• Across the five-year window, Capital Expenditures sank 35.49% in 2023 and surged 42.9% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $18.3 million in 2022, then tumbled by 35.49% to $11.8 million in 2023, then increased by 8.34% to $12.8 million in 2024, then climbed by 28.11% to $16.3 million in 2025, then increased by 4.7% to $17.1 million in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $17.1 million, $16.3 million, and $17.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.